Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Osteoporosis Medicine Decision Welcomed

MEDIACOM-RELEASE-MERCK-SHARP-&-DOHME

OSTEOPOROSIS MEDICINE DECISION WELCOMED

The decision to subsidise the osteoporosis medication Fosamax r from next month is an excellent start toward improving the quality of life for the estimated 30% of New Zealand women over the age of 50 who have osteoporosis, the medicine's manufacturer said today (Monday 17 January 2000).

"It is pleasing that New Zealand's most severe osteoporosis sufferers can join the 3.5 million people worldwide who are having their condition treated with Fosamax," Alister Brown, Managing Director of Merck Sharp and Dohme (NZ) Ltd. said today.

"Fosamax is the only medicine available for osteoporosis conclusively proven to reduce the risk of further fractures at the key osteoporosis sites - the hip, spine and wrist. Its subsidised availability here has been long awaited."

Fosamax has been available in this country since late 1995, and currently about 400 New Zealand sufferers pay the full cost of the medication.

From February 1, New Zealand specialists will be able to provide fully subsidised access to Fosamax for patients with two prior osteoporotic fractures and very low bone mass (three standard deviations below the mean normal value in young adults).

"We look forward to a greater number of New Zealand osteoporosis sufferers being granted access to Fosamax in the not too distant future," Mr Brown concluded.

ENDS...



© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Interim Crown Accounts: Minister Sees Strong Economic Fundamentals

Stronger-than-forecast wage and employment growth, and higher company profits are shown in the figures for the eleven months to 31 May. More>>

ALSO:

1.5 Percent: Official Cash Rate Unchanged

The Official Cash Rate (OCR) remains at 1.5 percent. Given the weaker global economic outlook and the risk of ongoing subdued domestic growth, a lower OCR may be needed over time to continue to meet our objectives. More>>

ALSO:

IMF On NZ: Near-Term Boost, Risks Tilted To Downside

New Zealand's economic expansion has lost momentum and while the near-term outlook is expected to improve, risks are increasingly tilted to the downside, according to the International Monetary Fund. More>>

ALSO:

Traceability: NZ To Track Satellites, Eggs

The New Zealand Space Agency (NZSA) is continuing to build its capability as a regulator of space activity with a new pilot project which allows officials to see real-time information on the orbital position of satellites launched from New Zealand. More>>

ALSO:

OECD On NZ: NZ's Living Standards Framework Positive But Has Gaps

Treasury’s living standards framework reflects good practice internationally but has some data gaps, including in areas where New Zealand fares poorly, the Organisation for Economic Cooperation and Development says. More>>

ALSO:

RBNZ Act Review: Govt Plans Deposit Guarantee Scheme

The Coalition Government today announced moves to make New Zealand’s banking system safer for customers through a new deposit protection regime, and work to strengthen accountability for banks’ actions. More>>

ALSO: